Skip to main content

Table 1 Study variables and assessment time

From: Effectiveness of iconic therapy for the reduction of borderline personality disorder symptoms among suicidal youth: study protocol for a randomised controlled trial

Instrument

Assessment area

Time of assessment

Primary outcomes

 BSL-23a

BPD symptoms severity

Baseline

After treatment

At 12 months

Secondary outcomes

 C-SSRSb

Suicidal ideation or behaviour

Baseline

After treatment

At 12 months

 DSM-V criteriac

Non-suicidal self-injury diagnosis

Baseline

After treatment

At 12 months

 CSRId

Economic evaluation

Baseline

At 12 months

Subsidiary measures

 IGe

Daily life adjustment

Baseline

After treatment

At 12 months

 CEQf

Credibility/expectancy questionnaire

After treatment

At 12 months

 Ad hoc scalesg

Perceived subjective global improvement (self-reported)

After treatment

At 12 months

 Ad hoc scalesh

Perceived global improvement (family/friends reported)

After treatment

At 12 months

  1. Notes. BSL-23a (Borderline Symptom List- short form); C-SSRSb (Columbia Suicide History Form); DSM-V criteriac (Non-suicidal self-injure diagnosis according to the Diagnosis and Statistical Manual of Mental Disorders, DSM- V); CSRId (Client Service Receipt Inventory); IGe (maladjustment scale); CEQf (credibility/expectancy questionnaire); Ad hoc scalesg (Perceived subjective global improvement); Ad hoc scalesh (Family and friends’ perceived global improvement)